We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

63 hedge funds and large institutions have $225M invested in Minerva Neurosciences in 2016 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

583% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 6

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

197% more capital invested

Capital invested by funds: $75.6M → $225M (+$149M)

125% more funds holding

Funds holding: 28 → 63 (+35)

Holders
63
Holders Change
+35
Holders Change %
+125%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
41
Increased
16
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.6M
2
CAM
Cormorant Asset Management
Massachusetts
+$8.32M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$7.95M
4
Franklin Resources
Franklin Resources
California
+$6.76M
5
Millennium Management
Millennium Management
New York
+$6.41M

Top Sellers

Rank Fund Capital Flow
1
DADC
D.A. Davidson & Co
Montana
-$819K
2
UBS Group
UBS Group
Switzerland
-$290K
3
Goldman Sachs
Goldman Sachs
New York
-$275K
4
HCMT
Highland Capital Management (Texas)
Texas
-$165K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$630K +$472K +7,421 +2,541%
AllianceBernstein
27
AllianceBernstein
Tennessee
$597K +$465K +7,313 New
TCIM
28
TIAA CREF Investment Management
New York
$533K +$415K +6,528 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$523K +$406K +6,391 New
Handelsbanken Fonder
30
Handelsbanken Fonder
Sweden
$510K +$397K +6,250 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$498K +$388K +6,099 New
MIM
32
Monashee Investment Management
Massachusetts
$439K – – –
SM
33
Sabby Management
Florida
$388K +$302K +4,750 New
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$381K +$297K +4,670 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$342K +$267K +4,192 New
CAM
36
ClariVest Asset Management
California
$266K +$207K +3,263 New
TA
37
Teachers Advisors
New York
$265K +$206K +3,246 New
VEA
38
Virtus ETF Advisers
New York
$262K +$204K +3,204 New
M&T Bank
39
M&T Bank
New York
$260K +$202K +3,183 New
Charles Schwab
40
Charles Schwab
California
$256K +$199K +3,125 New
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$230K +$179K +2,813 New
Morgan Stanley
42
Morgan Stanley
New York
$208K +$24.3K +382 +18%
VAM
43
Visium Asset Management
New York
$203K +$158K +2,482 New
SSG
44
Summit Securities Group
New York
$179K +$139K +2,185 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$160K +$124K +1,955 New
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$156K +$122K +1,913 New
SCM
47
Sterling Capital Management
North Carolina
$139K +$28.7K +452 +36%
HCM
48
Highbridge Capital Management
New York
$138K +$107K +1,686 New
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$128K +$90.4K +1,422 +981%
PPA
50
Parametric Portfolio Associates
Washington
$107K +$83.5K +1,313 New
1
2
3

NERV Hedge Fund Activity: Q2 2016 in Review

63 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2016, worth a combined $225M — up 197% from $75.6M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new NERV positions and 6 closed out — a net gain of 35 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $17.6M. The largest seller was D.A. Davidson & Co, exiting entirely with an estimated $819K sold.

  • 63 institutional investors held Minerva Neurosciences (NERV) as of Q2 2016, up from 28 in Q1 2016.
  • Funds reported $225M of Minerva Neurosciences stock for Q2 2016, up 197% quarter-over-quarter.
  • 41 funds opened new Minerva Neurosciences positions in Q2 2016 and 6 closed out, a net change of +35 holders.
  • The largest Minerva Neurosciences buyer in Q2 2016 was Fidelity Investments, an estimated $17.6M added.
  • The largest Minerva Neurosciences seller in Q2 2016 was D.A. Davidson & Co, an estimated $819K sold.

Based on aggregated 13F filings for Q2 2016.